06 October 2021 |

Anaconda Biomed to close venture debt operation of up to €10 million with the EIB

BARCELONA, OCTOBER 6th 2021 – Anaconda Biomed to close venture debt operation of up to €10 million with the EIB to treat acute ischemic stroke (AIS).  EIB to provide venture debt funding of up to €10 million to support the development of Anaconda’s next generation of catheters to treat acute ischemic strokes (AIS). This venture debt operation is supported by the European Guarantee

04 December 2019 |

Anaconda Biomed secures €20 Million round of funding

BARCELONA, Spain – Anaconda Biomed S,L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding will be used for clinical studies of the company’s groundbreaking technology, regulatory submissions in international markets, further product development and manufacturing scale-up. “With this new round of funding, we will be